Skip to content
Save 5% on your next order with code PREMIUM5!
100,000+ Products for Home, Medical, Office & Classroom Needs
Search
Skip to product information
1 of 1

Leukemia and Lymphoma: Molecular and Therapeutic Insights - Hardcover

$57.71 USD
$57.71 USD
Sale Sold out
Shipping calculated at checkout.

Available Offers

Fast delivery available on most orders

Multiple secure payment options accepted

Secure checkout with
  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • PayPal
  • Shop Pay
  • Visa

Flight Range: Up to 1,000 meters (3,280 feet)

Maximum Speed: 45 kilometers per hour (28 miles per hour)

For all orders exceeding a value of 100USD shipping is offered for free.

Returns will be accepted for up to 10 days of Customer’s receipt or tracking number on unworn items. You, as a Customer, are obliged to inform us via email before you return the item.

Otherwise, standard shipping charges apply. Check out our delivery Terms & Conditions for more details.

View Product Details
Shopping cart
Product Product subtotal Quantity Price Product subtotal
Leukemia and Lymphoma: Molecular and Therapeutic Insights - Hardcover
Leukemia and Lymphoma: Molecular and Therapeutic Insights - Hardcover
Leukemia and Lymphoma: Molecular and Therapeutic Insights - Hardcover
$57.71/ea
$0.00
Sold out
$57.71/ea $0.00

Product Description

by Michael G. Kharas (Editor), Ross L. Levine (Editor), Ari M. Melnick (Editor)

Leukemia and lymphoma are cancers that affect white blood cells. There are several different types, each with different causes, symptoms, treatments, and survival rates. Acute lymphocytic leukemia (ALL), for example, is the most common childhood cancer, but these diseases can occur in individuals of all ages.

Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Medicine covers our current understanding of the molecular underpinnings of leukemia and lymphoma, as well as recent progress in development of therapies that target them. The contributors review the normal functions of hematopoietic stem cells--the precursors to white blood cells--and then examine the genetic, epigenetic, and cellular mechanisms that drive malignant transformation. The roles of clonal hematopoiesis, RNA-binding proteins, and alterations in metabolism and cell signaling (e.g., MAP kinase pathways) are among the topics covered in depth, along with the parts they play in specific types of leukemia and lymphoma.

In addition, the authors discuss state-of-the-art preclinical models of leukemia and lymphoma, existing and prospective therapeutic strategies, and how technologies such as next-generation sequencing have accelerated progress in the field. This volume is therefore a vital reference for all cancer biologists and clinician-scientists concerned with defeating these diseases.
Number of Pages: 520
Dimensions: 1.2 x 10.2 x 7.3 IN
Publication Date: November 30, 2020
you might like